WALTHAM, Mass., Oct. 01, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for ...
The Arkansas Children’s Research Institute (ACRI) has received $3.2 million from the National Institutes of Health (NIH) to identify how pregnant moms and their babies can better and more safely ...
Organizers of the University of Manitoba’s edition of the Shinerama fundraiser are pictured recently. The students will be holding three events across the city on Oct. 2 to raise awareness about the ...
D Molecular Therapeutics (FDMT) offers attractive growth potential with strong cash reserves and promising late-stage gene therapy programs. See more here.
The funding will support the firm's pipeline of mRNA and gene correction therapies, including an investigational inhaled mRNA therapy under testing for cystic fibrosis.
This Friday, October 3rd, the Cystic Fibrosis Foundation will host its Little Rock Finest event at 6:30 p.m. in Argenta Plaza, bringing together the best of the ...
UK’s National Health Service (NHS) is facing criticism for linking first-cousin marriages to “stronger extended family support” and economic benefits..
Tory MP Richard Holden said the NHS should ‘stop taking the knee to damaging and oppressive cultural practices’ ...
ReCode Therapeutics, a clinical-stage genetic medicines company using tissue-specific delivery to power the next wave of mRNA and gene correction therapeutics, today announced the close of over $29 ...
Idorsia Pharmaceuticals Ltd. has divulged macrocyclic compounds acting as cystic fibrosis transmembrane conductance regulator (CFTR) modulators reported to be useful for the treatment of cystic ...
Staff at CARSTAR Hamilton Midtown and CARSTAR Hamilton Lockwood are celebrating a successful community-driven event that raised ...
The global cystic fibrosis therapeutics market size is calculated at USD 11.81 billion in 2025 and is expected to reach around USD 39.15 billion by 2034, growing at a CAGR of 14.24% for the forecasted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback